Relationship of mechanical dyssynchrony to QT interval prolongation in hypertrophic cardiomyopathy

被引:19
|
作者
Badran, Hata Mahfouz [1 ]
Elnoamany, Mohamed Fahmy [1 ]
Soltan, Ghada [1 ]
Ezat, Mohamed [1 ]
Elsedi, Mohamed [1 ]
Abdelfatah, Raed Ahmed [1 ]
Yacoub, Magdi [2 ]
机构
[1] Menoufiya Univ, Dept Cardiol, Tanta 0350, Gharbia, Egypt
[2] Univ London Imperial Coll Sci Technol & Med, London, England
关键词
Mechanical dyssynchrony; QT interval; Hypertrophic cardiomyopathy; VENTRICULAR ELECTROMECHANICAL ASYNCHRONY; CARDIAC-RESYNCHRONIZATION THERAPY; CHRONIC HEART-FAILURE; SUDDEN-DEATH; LONG QT; MYOCARDIAL DEFORMATION; PROGNOSTIC VALUE; HIGH-RISK; DISPERSION; STRAIN;
D O I
10.1093/ejechocard/jer290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Hypertrophic cardiomyopathy (HCM) is usually associated with electrocardiographic (ECG) abnormalities. QT interval and its dispersion can be clinical markers of electrophysiological instability and ventricular arrhythmias. We aimed to clarify the relation of QT variables to mechanical dyssynchrony and myocardial function in HCM. Methods and results The study population comprised 82 HCM patients, 28 healthy subjects as control. We assessed regional deformation indexes using vector velocity imaging in 12 myocardial segments. Peak systolic strain (epsilon(sys)), strain rate (SRsys), and post-systolic strain (PSS) were measured. Contraction time (CT) was measured from regional strain curves for each segment, as the time from the beginning of the Q-wave to the time-to-peak epsilon(sys) (TPS), mechanical dyssynchrony was estimated as TPS-SD. From 12-lead surface ECG, QT interval, QT dispersion, and its corrected values were measured. According to QT(c) (QT(c) >= 440 or <440 ms), patients were categorized into two groups: long QT and normal QT HCM. In the long QT group, QT(cd) and CT in all left ventricular (LV) segments were significantly prolonged; epsilon(sys), and SRsys were markedly attenuated compared with the other two groups (P < 0.001). LV dyssynchrony was significantly greater (P < 0.001) and PSS was more frequent in long QT HCM compared with the other two groups (P < 0.001). TPS-SD was correlated positively with QT(c) (r = 0.38, P < 0.01) and QT(cd) (r = 0.45, P < 0.001). QT(c) >= 440 ms identified LV mechanical dyssynchrony with 70% sensitivity, 100% specificity, and positive predictive value. Conclusion QT interval prolongation on surface ECG shows significant association with mechanical dyssynchrony and LV dysfunction in HCM. This may add pathophysiological insight into understanding ECG changes in such myocardial disease.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 50 条
  • [41] QT interval prolongation in diphenhydramine toxicity
    Thakur, AC
    Aslam, AK
    Aslam, AF
    Vasavada, BC
    Sacchi, TJ
    Khan, IA
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (02) : 341 - 343
  • [42] Cocaine induced prolongation of the QT interval
    Taylor, D
    Parish, D
    Thompson, L
    Cavaliere, M
    EMERGENCY MEDICINE JOURNAL, 2004, 21 (02) : 252 - 253
  • [43] Prolongation of the QT interval in primary aldosteronism
    Matsumura, K
    Fujii, K
    Kansui, Y
    Arima, H
    Iida, M
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (1-2) : 66 - 69
  • [44] Antipsychotic Drugs and QT Interval Prolongation
    Wojciech Zareba
    David A. Lin
    Psychiatric Quarterly, 2003, 74 : 291 - 306
  • [46] Rivastigmine and QT interval prolongation - Reply
    Walsh, E
    BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 : 550 - 551
  • [47] PROLONGATION OF THE QT INTERVAL IN PATIENTS WITH EPILEPSY
    RAINEY, JM
    CHAYASIRISOBHON, S
    EPILEPSIA, 1983, 24 (01) : 115 - 115
  • [48] QT-interval prolongation with ecstasy
    Drake, WM
    Broadhurst, PA
    SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (02): : 180 - 181
  • [49] Psychoactive Drugs and Prolongation of the QT Interval
    Deruvo, Gaetano
    Vendramin, Andrea
    Di Sciascio, Guido
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2009, 11 (04) : 11 - 19
  • [50] Citalopram (Celexa) and QT Interval Prolongation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1398): : 71 - 72